Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 5, 2010
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas
Erica D Warlick, Marcie Tomblyn, Qing Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial
Uday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Bone Marrow Transplantation
|
October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Blood
|
August 15, 2022
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages
Simone Feurstein, Amy M Trottier, Noel Estrada-Merly, et al.
American Journal of Hematology
|
February 5, 2024
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, et al.
Transplantation and Cellular Therapy
|
November 27, 2022
Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines
Zachariah DeFilipp, Stefan O Ciurea, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 23, 2013
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
Qaiser Bashir, Hassan Khan, Peter F Thall, et al.
Transplantation and Cellular Therapy
|
May 26, 2022
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes
Gheath Alatrash, Chantal Saberian, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 7, 2016
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results
Partow Kebriaei, Roland Bassett, Genevieve Lyons, et al.
Transplantation and Cellular Therapy
|
December 5, 2022
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection
Rohtesh S Mehta, Kai Cao, Rima M Saliba, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 5, 2010
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas
Erica D Warlick, Marcie Tomblyn, Qing Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial
Uday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Bone Marrow Transplantation
|
October 11, 2021
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Qaiser Bashir, Denái R Milton, Uday R Popat, et al.
Blood
|
August 15, 2022
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages
Simone Feurstein, Amy M Trottier, Noel Estrada-Merly, et al.
American Journal of Hematology
|
February 5, 2024
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study
Sairah Ahmed, Qaiser Bashir, Roland L Bassett, et al.
Transplantation and Cellular Therapy
|
November 27, 2022
Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines
Zachariah DeFilipp, Stefan O Ciurea, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 23, 2013
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
Qaiser Bashir, Hassan Khan, Peter F Thall, et al.
Transplantation and Cellular Therapy
|
May 26, 2022
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes
Gheath Alatrash, Chantal Saberian, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 7, 2016
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results
Partow Kebriaei, Roland Bassett, Genevieve Lyons, et al.
Transplantation and Cellular Therapy
|
December 5, 2022
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection
Rohtesh S Mehta, Kai Cao, Rima M Saliba, et al.
Page
of 15